Who are the women blazing trails in biopharma R&D? Nominate them for Endpoints' special report
Gender imbalance in the average corporate boardroom is endemic, and the biopharma world is no exception. Data suggest women are woefully underrepresented in leadership roles, holding just 20% of these seats at biopharma firms.
Last year, when we asked the Endpoints 100 — the group of biotech execs we rely on to measure industry-wide sentiments in a semi-annual survey — how the industry was performing on gender diversity, there was a consensus that it could do better. One way to do this, is to encourage and celebrate the women who have climbed the ladder, despite the odds.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
